Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Peter Rahmer is See remarks at Relay Therapeutics. OQRO lists 15 transactions filed with the SEC under this name, the latest on Oct 30, 2026, each linked to the official Form 4.
See remarks
Disclosures on record
15
Companies involved
1
Relay TherapeuticsRLAY
15 disclosures · Oct 2024 – Oct 2026 · 15 sold
Oct 28, 2026Sold~$14Kdisclosed Oct 30
DetailsOfficial recordJul 29, 2025Sold~$58Kdisclosed Jul 30
DetailsJul 28, 2025Sold~$5.1Kdisclosed Jul 30
DetailsOfficial recordApr 30, 2025Sold~$32Kdisclosed May 1
DetailsOfficial recordApr 28, 2025Sold~$4.3Kdisclosed May 1
DetailsOfficial recordMar 27, 2025Sold~$701disclosed Mar 31
DetailsOfficial recordJan 29, 2025Sold~$121Kdisclosed Jan 31
DetailsOfficial recordJan 30, 2025Sold~$76Kdisclosed Jan 31
DetailsOfficial recordJan 28, 2025Sold~$7.7Kdisclosed Jan 31
DetailsOfficial recordJan 3, 2025Sold~$138Kdisclosed Jan 7
DetailsOfficial recordJan 2, 2025Sold~$133Kdisclosed Jan 7
DetailsOfficial recordJan 6, 2025Sold~$74Kdisclosed Jan 7
DetailsOfficial recordDec 27, 2024Sold~$1.8Kdisclosed Dec 31
DetailsOfficial recordOct 28, 2024Sold~$9.8Kdisclosed Oct 30
DetailsOfficial recordSep 27, 2024Sold~$1.8Kdisclosed Oct 1
DetailsOfficial recordAs of the latest filing on , Peter Rahmer reported holding 222,904 shares of Relay Therapeutics (RLAY), worth about $4.03M at the last close of $18 (Nov 13, 2026). In the last 12 months, Peter Rahmer sold $14K in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Relay Therapeutics RLAY | 222,904 | 223K direct | $18 | $4.03M | Oct 28, 2026 |
Is this Peter Rahmer’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Oct 28, 2026, Peter Rahmer reported holding 222,904 shares of Relay Therapeutics (RLAY). At the last close of $18 on Nov 13, 2026, that is about $4.03M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Peter Rahmer reported 1 open-market sale worth $14K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Peter Rahmer has no open-market purchase on record since 2023. Sales in each of the last 4 years.
In SEC filings since 2023: no open-market purchase is on record; the latest open-market sale is from 2026.
Relay Therapeutics (RLAY), from 2023 to 2026: 0 purchases and 34 sales.
Peter Rahmer has no open-market purchase on record since 2023. Sales in each of the last 4 years.
Peter Rahmer reported 0 open-market purchases and 34 sales since 2023; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $14K1×1 trade |
| 2025 | — | $651K11×11 trades |
| 2024 | — | $935K13×13 trades |
| 2023 |
$79K9×9 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Peter Rahmer reported 0 open-market purchases and 34 sales here, 2023 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
